Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kiyoshi Yoshimura

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Nature Medicine|January 31, 2006
Interferon-producing killer dendritic cells provide a link between innate and adaptive immunityCamie W Chan, Emily Crafton, Hong-Ni Fan, et al.
Cancer Research|February 3, 2006
Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signalingRajani Ravi, Ephraim J Fuchs, Ajay Jain, et al.
Digestive Diseases and Sciences|March 18, 2008
Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a post-Barrett's esophagus settingTomoharu Miyashita, Furhawn A Shah, Guy P Marti, et al.
Cancer Immunology, Immunotherapy : CII|May 19, 2015
Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trialYoshinari Maeda, Kiyoshi Yoshimura, Hiroto Matsui, et al.
Anticancer Research|April 28, 2025
Efficacy of Esophagectomy Following Neoadjuvant Chemotherapy for Esophageal Neuroendocrine CarcinomaTakeshi Yamashita, Koichiro Fujimasa, Koji Otsuka, et al.
Anticancer Research|September 15, 2019
Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint InhibitorsKiyohiro Ando, Kazuyuki Hamada, Makoto Watanabe, et al.
Pancreas|July 12, 2017
Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive ImmunotherapyHiroto Matsui, Shoichi Hazama, Kazuhiko Sakamoto, et al.
International Journal of Oncology|August 15, 2014
A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched populationYusaku Watanabe, Kiyoshi Yoshimura, Koichi Yoshikawa, et al.
Pancreas|February 10, 2021
The Prognostic Impact of Eosinophils and the Eosinophil-to-Lymphocyte Ratio on Survival Outcomes in Stage II Resectable Pancreatic CancerRyotaro Ohkuma, Yutaro Kubota, Atsushi Horiike, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[A resected case of hilar cholangiocarcinoma treated with neoadjuvant chemoradiation therapy]Kensuke Yamada, Kazuhiko Sakamoto, Takao Tamesa, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Nature Medicine|January 31, 2006
Interferon-producing killer dendritic cells provide a link between innate and adaptive immunityCamie W Chan, Emily Crafton, Hong-Ni Fan, et al.
Cancer Research|February 3, 2006
Resistance of cancers to immunologic cytotoxicity and adoptive immunotherapy via X-linked inhibitor of apoptosis protein expression and coexisting defects in mitochondrial death signalingRajani Ravi, Ephraim J Fuchs, Ajay Jain, et al.
Digestive Diseases and Sciences|March 18, 2008
Vaccine impedes the development of reflux-induced esophageal cancer in a surgical rat model: efficacy of the vaccine in a post-Barrett's esophagus settingTomoharu Miyashita, Furhawn A Shah, Guy P Marti, et al.
Cancer Immunology, Immunotherapy : CII|May 19, 2015
Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trialYoshinari Maeda, Kiyoshi Yoshimura, Hiroto Matsui, et al.
Anticancer Research|April 28, 2025
Efficacy of Esophagectomy Following Neoadjuvant Chemotherapy for Esophageal Neuroendocrine CarcinomaTakeshi Yamashita, Koichiro Fujimasa, Koji Otsuka, et al.
Anticancer Research|September 15, 2019
Plasma Levels of Soluble PD-L1 Correlate With Tumor Regression in Patients With Lung and Gastric Cancer Treated With Immune Checkpoint InhibitorsKiyohiro Ando, Kazuyuki Hamada, Makoto Watanabe, et al.
Pancreas|July 12, 2017
Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive ImmunotherapyHiroto Matsui, Shoichi Hazama, Kazuhiko Sakamoto, et al.
International Journal of Oncology|August 15, 2014
A stem cell medium containing neural stimulating factor induces a pancreatic cancer stem-like cell-enriched populationYusaku Watanabe, Kiyoshi Yoshimura, Koichi Yoshikawa, et al.
Pancreas|February 10, 2021
The Prognostic Impact of Eosinophils and the Eosinophil-to-Lymphocyte Ratio on Survival Outcomes in Stage II Resectable Pancreatic CancerRyotaro Ohkuma, Yutaro Kubota, Atsushi Horiike, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2014
[A resected case of hilar cholangiocarcinoma treated with neoadjuvant chemoradiation therapy]Kensuke Yamada, Kazuhiko Sakamoto, Takao Tamesa, et al.
Pageof 11